Loading...
Loading...
CERT| Name | Value |
|---|---|
| Revenues | 94.8M |
| Cost of Revenue | 37.2M |
| Gross Profit | 57.6M |
| Operating Expense | 55.0M |
| Operating I/L | 2.6M |
| Other Income/Expense | -4.3M |
| Interest Income | 0.0M |
| Pretax | -1.7M |
| Income Tax Expense | -0.3M |
| Net Income/Loss | -1.4M |
Certara, Inc. provides software products and technology-enabled services for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. The company's offerings include mechanistic and empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access services. Additionally, Certara offers a range of software products such as mechanistic and empirical biosimulation platforms, data standardization and compliance software, scientific informatics platform, and authoring and management of regulatory submissions platform.
